Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis.

Al Dhaybi R, Sartelet H, Powell J, Kokta V.

Mod Pathol. 2010 Mar;23(3):376-80. doi: 10.1038/modpathol.2009.163.

2.

CD133 as a marker for cancer stem cells: progresses and concerns.

Wu Y, Wu PY.

Stem Cells Dev. 2009 Oct;18(8):1127-34. doi: 10.1089/scd.2008.0338. Review.

PMID:
19409053
3.

Research progression of CD133 as a marker of cancer stem cells.

Zhang H, Li SY.

Chin J Cancer. 2010 Mar;29(3):243-7. Review.

4.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Review.

5.

How powerful is CD133 as a cancer stem cell marker in brain tumors?

Cheng JX, Liu BL, Zhang X.

Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Review.

PMID:
19369008
6.

CD133: molecule of the moment.

Mizrak D, Brittan M, Alison M.

J Pathol. 2008 Jan;214(1):3-9. Review.

PMID:
18067118
7.

[The role of tyrosine phosphorylation of cancer stem cell marker CD133 in malignant tumor progression].

Shimozato O, Nagase H, Ozaki T.

Seikagaku. 2015 Jun;87(3):389-92. Review. Japanese. No abstract available.

PMID:
26571608
8.

Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L, Dong L, Andera L, Ralph SJ.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):855-9. Review.

PMID:
17307142
9.

Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.

Scolyer RA, Murali R, McCarthy SW, Thompson JF.

Arch Pathol Lab Med. 2010 Dec;134(12):1770-7. doi: 10.1043/2009-0612-RAR.1. Review.

PMID:
21128774
10.

Targeting CD133 antigen in cancer.

Ferrandina G, Petrillo M, Bonanno G, Scambia G.

Expert Opin Ther Targets. 2009 Jul;13(7):823-37. doi: 10.1517/14728220903005616. Review.

PMID:
19530986
11.

Human breast and melanoma cancer stem cells biomarkers.

La Porta CA, Zapperi S.

Cancer Lett. 2013 Sep 10;338(1):69-73. doi: 10.1016/j.canlet.2012.03.017. Review.

PMID:
22445909
12.

Spitz nevus arising in the eyelid of a teenager.

Shields PW, Jakobiec FA, Stagner AM, Yoon MK.

Surv Ophthalmol. 2016 Mar-Apr;61(2):228-35. doi: 10.1016/j.survophthal.2015.10.002. Review.

PMID:
26498574
13.

Finding the root of the problem: the quest to identify melanoma stem cells.

Abel EV, Aplin AE.

Front Biosci (Schol Ed). 2011 Jun 1;3:937-45. Review.

PMID:
21622243
14.

Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.

Seftor EA, Seftor RE, Weldon DS, Kirsammer GT, Margaryan NV, Gilgur A, Hendrix MJ.

Semin Oncol. 2014 Apr;41(2):259-66. doi: 10.1053/j.seminoncol.2014.02.001. Review.

Supplemental Content

Support Center